[HTML][HTML] Estrogen-receptor expression and function in female reproductive disease

ZR Tang, R Zhang, ZX Lian, SL Deng, K Yu�- Cells, 2019 - mdpi.com
Estrogen receptors (ER) include ER alpha, ER beta and new membrane receptor G protein-
coupled receptor 30 (GPR30). Estrogen receptors are key receptors to maintain ovarian�…

[HTML][HTML] Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)—searching for epigenetic factors

D Szukiewicz, S Trojanowski, A Kociszewska…�- International journal of�…, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of
reproductive age. Despite its incidence, the syndrome is poorly understood and remains�…

[HTML][HTML] The genetics of polycystic ovary syndrome: an overview of candidate gene systematic reviews and genome-wide association studies

D Hiam, A Moreno-Asso, HJ Teede, JSE Laven…�- Journal of clinical�…, 2019 - mdpi.com
Polycystic Ovary Syndrome (PCOS) is a complex condition with mechanisms likely to involve
the interaction between genetics and lifestyle. Familial clustering of PCOS symptoms is well�…

The role of genetics, epigenetics and lifestyle in polycystic ovary syndrome development: the state of the art

V Bruni, A Capozzi, S Lello�- Reproductive Sciences, 2022 - Springer
Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disease affecting about 20–
25% of women in reproductive age. Different mechanisms could contribute to the�…

[HTML][HTML] Molecular features of polycystic ovary syndrome revealed by transcriptome analysis of oocytes and cumulus cells

J Li, H Chen, M Gou, C Tian, H Wang…�- Frontiers in cell and�…, 2021 - frontiersin.org
Polycystic ovary syndrome (PCOS) is typically characterized by a polycystic ovarian
morphology, hyperandrogenism, ovulatory dysfunction, and infertility. Furthermore, PCOS�…

Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome

Y Chen, G Wang, J Chen, C Wang, X Dong…�- Endocrine�…, 2024 - academic.oup.com
The treatment of polycystic ovary syndrome (PCOS) faces challenges as all known
treatments are merely symptomatic. The US Food and Drug Administration (FDA) has not�…

High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary�…

RK Patten, LC McIlvenna, I Levinger…�- Human�…, 2022 - academic.oup.com
STUDY QUESTION Does 12 weeks of high-intensity interval training (HIIT) result in greater
improvements in cardio-metabolic and reproductive outcomes compared to standard�…

[HTML][HTML] Naturally occurring and experimentally induced rhesus macaque models for polycystic ovary syndrome: translational gateways to clinical application

DH Abbott, J Rogers, DA Dumesic, JE Levine�- Medical Sciences, 2019 - mdpi.com
Indian rhesus macaque nonhuman primate models for polycystic ovary syndrome (PCOS)
implicate both female hyperandrogenism and developmental molecular origins as core�…

[HTML][HTML] Skeletal muscle methylome and transcriptome integration reveals profound sex differences related to muscle function and substrate metabolism

S Landen, M Jacques, D Hiam, J Alvarez-Romero…�- Clinical�…, 2021 - Springer
Nearly all human complex traits and diseases exhibit some degree of sex differences, with
epigenetics being one of the main contributing factors. Various tissues display sex�…

Role of genomic DNA methylation in PCOS pathogenesis: a systematic review and meta-analysis involving case-controlled clinical studies

K Rawat, A Sandhu, V Gautam…�- Molecular Human�…, 2022 - academic.oup.com
Polycystic ovary syndrome (PCOS) is often associated with aberrant DNA methylation.
Despite the advances in diagnostics and treatment of PCOS, the pathophysiological�…